semaglutide and diverticulosis Ozempic Diverticulitis: Exploring the Possible Link Mayo Clinic Q and A:

In most cases, their hair loss isnt caused by the medication damaging their follicles

placebo INDIANAPOLIS, May 21, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes

Memory and hormonal support: Slow-wave sleep promoted by DSIP contributes to better memory processing and optimal hormone secretion

The aim was to assess the prevalence of hyperglycaemia in people treated with systemic glucocorticoids for COPD